Giles Roditi

Dr. Giles Roditi is an Honorary Professor at the University of Glasgow's School of Cardiovascular & Metabolic Health, affiliated with the British Heart Foundation (BHF) Cardiovascular Research Centre. His research focuses on cardiovascular imaging, renal medicine, and heart failure, with a particular emphasis on MRI techniques and post-COVID-19 cardiac sequelae. He has contributed to studies on anti-VEGF cardiotoxicity, pandemic imaging strategies, and vascular mapping in chronic kidney disease.

• Affiliations: University of Glasgow, BHF Cardiovascular Research Centre
• Key Research Areas: Cardiac MRI, cardiovascular disease pathophysiology, post-hospitalization outcomes

His work integrates clinical imaging with translational research, addressing topics such as nephrogenic systemic fibrosis, contrast agent safety, and therapeutic interventions in renal artery stenosis. Dr. Roditi has collaborated widely, leading or co-authoring over 90 publications since 2009, including studies on SCOT-HEART trial outcomes and the CISCO-19 imaging initiative during the pandemic.

Notably, he has explored the role of imaging in guiding therapy for coronary artery disease and has been involved in randomized controlled trials evaluating vitamin K supplementation in kidney transplant recipients.